| Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection S Petta, C Camma, V Di Marco, N Alessi, D Cabibi, R Caldarella, A Licata, ... Official journal of the American College of Gastroenterology| ACG 103 (5 …, 2008 | 219 | 2008 |
| Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease? OL Iacono, S Petta, G Venezia, V Di Marco, G Tarantino, F Barbaria, ... Official journal of the American College of Gastroenterology| ACG 100 (11 …, 2005 | 101 | 2005 |
| Retinol‐binding protein 4: a new marker of virus‐induced steatosis in patients infected with hepatitis c virus genotype 1 S Petta, C Camma, V Di Marco, N Alessi, F Barbaria, D Cabibi, ... Hepatology 48 (1), 28-37, 2008 | 82 | 2008 |
| Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non‐alcoholic steatohepatitis G Tarantino, P Conca, A Coppola, R Vecchione, G Di Minno European journal of clinical investigation 37 (1), 48-53, 2007 | 65 | 2007 |
| Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases D Cabibi, G Tarantino, F Barbaria, M Campione, A Craxì, V Di Marco Digestive and liver disease 42 (8), 585-592, 2010 | 33 | 2010 |
| Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C G Tarantino, D Cabibi, C Camma, N Alessi, M Donatelli, S Petta, A Craxi, ... Journal of viral hepatitis 15 (7), 523-530, 2008 | 31 | 2008 |
| Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a … S Petta, M Marzioni, P Russo, A Aghemo, A Alberti, A Ascione, A Antinori, ... The Lancet Gastroenterology & Hepatology 2 (6), 427-434, 2017 | 25 | 2017 |
| Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection G Tarantino, VD Marco, S Petta, PL Almasio, F Barbaria, A Licata, ... Journal of viral hepatitis 16 (6), 397-405, 2009 | 24 | 2009 |
| Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren’s syndrome P Fraticelli, P Bagnarelli, G Tarantino, GP Martino, D Benfaremo, L Nobili, ... Rheumatology 55 (12), 2275-2277, 2016 | 22 | 2016 |
| Optimizing the treatment of chronic hepatitis due to hepatitis C virus genotypes 2 and 3: a review G Tarantino, A Craxì Liver International 29, 31-38, 2009 | 20 | 2009 |
| Hepatitis E in a region of Italy: An emerging autochthonous infection? G Tarantino, P Bagnarelli, M Marzioni, K Marinelli, G Surace, S Traini, ... Digestive and Liver Disease 48 (11), 1340-1345, 2016 | 14 | 2016 |
| In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C. G Tarantino, A Di Cristina, R Pipitone, PL Almasio, G Di Vita, A Craxi, ... Journal of Biological Regulators and Homeostatic Agents 27 (1), 233-239, 2013 | 14 | 2013 |
| Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome G Tarantino, A Ortolani, K Marinelli, A Benedetti, G Marconi, M Calzolari, ... Digestive and Liver Disease 52 (4), 434-439, 2020 | 8 | 2020 |
| Congenital hepatic fibrosis: a very uncommon cause of pancytopenia in children A Trizzino, P Farruggia, D Russo, P D'Angelo, S Tropia, V Benigno, ... Journal of Pediatric Hematology/Oncology 27 (10), 567-568, 2005 | 6 | 2005 |
| Hepatitis E in a Region of Italy: An Autochthonous Emerging Infection? G Tarantino, G Surace, K Marinelli, M Marzioni, A Malena, S Menzo, ... Journal of Hepatology 64 (2), S458, 2016 | 2 | 2016 |
| Serum BLyS/BAFF levels in acute hepatitis C predict clinical outcome G Tarantino, V Di Marco, PL Almasio, F Barbaria, A Ciaccio, F D’Antoni, ... Digestive and Liver Disease 40 (5), A1-A2, 2008 | 1 | 2008 |
| Reversibility of fibrosis G Tarantino, A Craxi IMMUNOLOGY AND THE LIVER: INFLAMMATION, REPAIR AND THERAPIES, 201-206, 2006 | 1 | 2006 |
| Tenofovir and entecavir for chronic hepatitis B infection treatment: a single-center experience F Tarsetti, G Tarantino, P Mosca, E Scarpellini, G Fava Clinical Management Issues 9 (4), 95-100, 2015 | | 2015 |
| Retinol-binding protein 4 (RBP4): A new marker of G1 HCV-induced steatosis S Petta, C Cammà, V Di Marco, F Barbaria, D Cabibi, R Caldarella, ... Digestive and Liver Disease 40 (5), A29-A30, 2008 | | 2008 |
| 751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS S Petta, C Camma, V Di Marco, F Barbaria, D Cabibi, R Caldarella, ... Journal of Hepatology 48, S280-S280, 2008 | | 2008 |
Antonio CraxiFull Professor of Gastroenterology and Internal Medicine, PROMISE, University of Palermo, ItalyZweryfikowany adres z unipa.it
